Press Release|

SHL Medical launches dynamic webpage for Molly autoinjector technology

Molly Wepage

SHL Medical, a leading solutions provider in the design, development, and manufacturing of self-injection technologies, announced the launch of its Molly autoinjector webpage.

The newly launched webpage features the Molly modular platform technology, one of SHL’s most significant device offerings that are leading the market today. The page offers its visitors a three-dimensional experience brought about by its animated parallax scrolling effect. It details the entire Molly device offering, covering customizable device designs, flexible and scalable production infrastructures, as well as constant modular expansions to the Molly ecosystem that cover digital health and sustainability. The webpage is the culmination of research and discussions with various SHL subject-matter experts knowledgeable about the device technology.

“Drawing from the successes of its originally preconfigured platform predecessor, this new generation of Molly incorporates modularity across the combination product development stream. With this new Molly microsite, the industry can gain an in-depth understanding of our modular platform device technology that goes beyond the confines of platform conventionality. SHL Medical is truly proud to share this dynamic Molly webpage for the general audience to explore and learn more about the technology up close,” SHL Medical Director of Marketing Magnus Fastmarken said.

 

 

Alternatively, visitors can access the microsite via https://molly.shl-medical.com/

About SHL Medical

As a world-leading solutions provider of advanced drug delivery systems, SHL Medical is the partner of choice for many leading pharma and biotech companies. Driven by our company purpose – Enabling Patients’ Independence – we offer patient-centric solutions for the design, development, and manufacturing of autoinjectors, pen injectors, as well as innovative specialty delivery systems for large-volume and high-viscosity formulations. We also offer final assembly, labeling, and packaging solutions for our drug delivery systems.  ​

In response to the rising trend in home therapy, SHL has increased developmental work in the digital healthcare sector to help improve the drug delivery ecosystem

Located across Switzerland, Taiwan, Sweden, and the US, our global team of experts collaborate seamlessly as one team in utilizing our comprehensive in-house manufacturing capabilities. Our solutions offer customization and optimization for each project while proactively weaving sustainability-driven measures into our designs and processes to contribute to a cleaner earth.​

For additional information, visit www.shl-medical.com

Media contact: info@shl-medical.com

Share:

Related News

SHL Medical, a world-leading solutions provider of advanced drug delivery systems such as autoinjectors, pen injectors, and innovative specialty delivery systems has announced a strategic partnership with Grand River Aseptic Manufacturing (GRAM), a highly regarded contract development and manufacturing organization (CDMO) specializing in sterile injectable biologics and scalable pharmaceutical manufacturing solutions tailored to diverse client needs.